Approvals/TGA/Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack

Approved

STANDARD

Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5e2a9ca3e7b1f471
Product Name: Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack
Artg Id: 384183
Artg Name: Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2022-06-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

5e2a9ca3e7b1f471

Type

Standard